Skip to main content
Displaying 37 - 48 of 52
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
What can we learn about holistic care to manage cholestatic pruritus in PBC from a US healthcare setting?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Closing remarks
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Final audience questions
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Should we focus on managing QoL?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Debate the issues
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Event summary
Webcasts
View
Immune-Mediated and Cholestatic Diseases
How do we holistically treat patients with PBC?
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Should we focus on monitoring ALP?
Webcasts
View
Metabolism, Alcohol & Toxicity
Wrap-up
Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Page
3
Current page
4
Page
5
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy